Navigation Links
Tobira Therapeutics, Inc. to Present at the 2008 BIO Investor Forum
Date:10/23/2008

-Sapirstein to Present Company Overview-

PRINCETON, N.J. and SAN DIEGO, Oct. 23 /PRNewswire/ -- Tobira Therapeutics, Inc., a company focused on the development of medicines with novel mechanisms of actions for infectious diseases, today announced it will present a corporate overview at the 2008 BIO Investor Forum. James Sapirstein, Chief Executive Officer and President will summarize the current status of the company including the status of TBR-652, a CCR5 antagonist in development for HIV-1 infection in adults. The presentation is scheduled for October 30, 2008 at 9:00 AM PST at The Palace Hotel, Two New Montgomery Street, San Francisco, Calif.

"We are delighted to share the growth Tobira Therapeutics, Inc. has experienced in the last 18 months at the BIO Investor Forum," said James Sapirstein. "This is a unique opportunity to review the great potential that we have to offer." Tobira Therapeutics is a clinical stage company and is not developing new technologies. The company is expanding its pipeline by being the partner of choice for suppliers, researchers, and alliance partners. A key component of Tobira's strategy is to acquire global rights to additional product candidates in infectious diseases, while continuing to develop and commercialize new products and line extensions.

The BIO Investor Forum will feature more than 190 public and venture-stage company presentations, in addition to drug and technology therapeutic workshops, breakout sessions, one-on-one investor meetings, and networking with industry executives and investors.

About Tobira Therapeutics, Inc.

Tobira Therapeutics is a private biopharmaceutical company which is focused on developing and commercializing innovative antiviral compounds to treat HIV disease. The company was founded in 2006 by Eckard Weber, MD, a partner at the venture capital firm Domain Associates, to develop novel treatments for HIV disease. Tobira has assembled a highly exp
'/>"/>

SOURCE Tobira Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Tobira Therapeutics Inc. Announces Senior Management Team
2. Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $24.7 Million of Senior Convertible Notes
3. Cell Therapeutics, Inc. (CTI) to Present at Three Upcoming Investor Conferences
4. Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $14.2 Million of Senior Convertible Notes
5. Intarcia Therapeutics, Inc. Announces Appointment of Kenneth Luskey, M.D. as Vice President, Clinical Research
6. Cell Therapeutics, Inc. Announces Reverse Stock Split
7. Cell Therapeutics, Inc.s Second Quarter 2008 Financial Results
8. Nile Therapeutics, Inc. Reports 2008 Second Quarter Financial Results
9. Zenobia Therapeutics, Inc. Receives Michael J. Fox Foundation for Parkinsons Research Award for Work on PD-implicated Protein LRRK2
10. Cell Therapeutics, Inc. Announces Single Institutional Investor to Purchase $44.5 Million of Units Consisting of Senior Convertible Notes and Warrants
11. Zenobia Therapeutics, Inc. Begins Operations as a Fragment-Based Lead Discovery Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... New programme aims to ... pharmaceutical and chemical sectors Pfizer Asia ... and Siemens Pte. Ltd, have signed on as ... Programme - Innovative Processing of Specialties and Pharmaceuticals ... Engineering Sciences (ICES), the consortium offers a platform ...
(Date:6/19/2013)... 2013 For an eco-friendly selection for ... Baths using metallic beads instead of water. The ... not require germicides. Yet, the bead bath delivers exceptional ... is always ready unlike a water bath, no warm-up ... bath, which eliminates the contamination and maintenance issues related ...
(Date:6/19/2013)... June 19, 2013 Bellevue city ... hall of technology solutions for people with disabilities ... Hyatt Regency Bellevue. , The exhibit hall, ... on Saturday and Sunday, will feature leading manufacturers ... wheelchairs, communication devices, eyegaze technologies, computer applications, and ...
(Date:6/19/2013)... June 19, 2013 An article posted earlier ... the increasing number of uses for probiotics. The article stated ... and the associate benefits may beeb listed, the actual ... and helping clear skin conditions. While the total uses of ... on the the uses of these “miracle” bacterium, and debunked ...
Breaking Biology Technology:Pfizer, GSK, and Siemens Form R&D Consortium With A*STAR's Institute of Chemical & Engineering Sciences 2Pfizer, GSK, and Siemens Form R&D Consortium With A*STAR's Institute of Chemical & Engineering Sciences 3Pfizer, GSK, and Siemens Form R&D Consortium With A*STAR's Institute of Chemical & Engineering Sciences 4Cole-Parmer Introduces Eco-Friendly Waterless Bead Baths 2City of Bellevue, Wash., Welcomes Assistive Technology Exhibit Hall 2Natural Acne Remedy, Probiotic Action Explains the Science behind Using Probiotics for Better Health 2
... CV Therapeutics,Inc. (Nasdaq: CVTX ) announced ... has approved new language for the product labeling ... ranolazine to inhibit the late sodium current at ... suggests that during ischemic,episodes excess sodium can flow ...
... GAITHERSBURG, Md., Dec. 18 Panacea Pharmaceuticals, ... named one of Time Magazine,s,Ten Biggest Medical ... URL, please cut,and paste into browser:, http://www.time.com/time/specials/2007/top10/article/0,30583,1686204_1686252_1690390, ... test to facilitate the identification,of lung cancer, ...
... WASHINGTON, Dec. 18 Trust for America,s,Health (TFAH) ... Protecting the,Public,s Health from Disease, Disasters, and Bioterrorism" ... made, critical areas of the,nation,s emergency health preparedness ... of annual cuts in federal funding for state,and ...
Cached Biology Technology:FDA Approves New Mechanism of Action Labeling for Ranexa(R) 2Panacea Pharmaceuticals' Lung Cancer Diagnostic Test, LC Detect(SM), Named One of Time Magazine's Ten Biggest Medical Breakthroughs of 2007 2Panacea Pharmaceuticals' Lung Cancer Diagnostic Test, LC Detect(SM), Named One of Time Magazine's Ten Biggest Medical Breakthroughs of 2007 3Panacea Pharmaceuticals' Lung Cancer Diagnostic Test, LC Detect(SM), Named One of Time Magazine's Ten Biggest Medical Breakthroughs of 2007 4Significant Progress Made in Nation's Preparedness to Respond to Public Health Emergencies; But Gaps in Critical Areas Threaten Overall Readiness 2Significant Progress Made in Nation's Preparedness to Respond to Public Health Emergencies; But Gaps in Critical Areas Threaten Overall Readiness 3Significant Progress Made in Nation's Preparedness to Respond to Public Health Emergencies; But Gaps in Critical Areas Threaten Overall Readiness 4Significant Progress Made in Nation's Preparedness to Respond to Public Health Emergencies; But Gaps in Critical Areas Threaten Overall Readiness 5
(Date:6/19/2013)... published in the journal Polar Biology, researchers report using DNA ... be a new type of killer whale ( Orcinus orca ... killer whales stranded on a New Zealand beach and a ... also taken but it was almost 50 years before this ... white eye-patch and bulbous forehead, was documented alive in the ...
(Date:6/19/2013)... the most potent physiological anabolic agent for tissue-building ... of lipids, protein and carbohydrates, and inhibiting their ... also plays a major role in stimulating glucose ... metabolized and removed from the blood following meals. ... mechanisms by which insulin regulates glucose uptake in ...
(Date:6/19/2013)... Midwest are expected to contribute to a very large ... according to a University of Michigan ecologist and colleagues ... for the Chesapeake Bay. , The Gulf forecast, one ... Administration, calls for an oxygen-depleted, or hypoxic, region of ... it among the 10 largest on record. , The ...
Breaking Biology News(10 mins):Breakthrough research of essential molecule reveals important targets in diabetes and obesity 2U-M researcher and colleagues predict possible record-setting Gulf of Mexico 'dead zone' 2U-M researcher and colleagues predict possible record-setting Gulf of Mexico 'dead zone' 3U-M researcher and colleagues predict possible record-setting Gulf of Mexico 'dead zone' 4
... their exposure to molds or dampness in their bedroom, and ... or smaller beneficial effect against asthma, according to a study ... C might be beneficial in the treatment of asthma date ... have been conflicting., Drs Mohammed Al-Biltagi from the Tanta University ...
... swine flu, virus outbreaks can be unpredictable and devastating. ... site Facebook, developed in a Tel Aviv University lab, is ... spread among populations. Dr. Gal Almogy and Prof. ... at TAU,s George S. Wise Faculty of Life Sciences have ...
... From the boiling depths of undersea hydrothermal vents to ... freezing cold of Antarctic glacial icemicroorganisms known as extremophiles ... on Earth. The unique biology of these microorganisms has ... help solve the problem of efficient and cost-effective processing ...
Cached Biology News:Watching viruses 'friend' a network 2Watching viruses 'friend' a network 3UGA symposium explores extreme microbes’ bioenergy potential 2